Impatient with years of inaction in Washington on prescription drug costs, U.S. hospital groups, startups and nonprofits have started making their own medicines in a bid to combat stubbornly high prices and persistent shortages ...
Aug 10, 2021
0
54
The U.S. biosimilar drug market emerged in 2015 to provide safe, effective, and more affordable alternatives to existing biologic drugs, but it has been slow to develop compared with Europe.
Jun 6, 2023
0
1
Lawmakers are trying to set aside their irreconcilable differences over the Obama-era Affordable Care Act and work to reach bipartisan agreement on a more immediate health care issue, lowering costs for people who already ...
Jul 7, 2019
1
0
Scientists have been telling Americans about the benefits of healthy eating for decades, and yet more Americans are obese than ever—more than a third of the country.
Mar 2, 2016
0
63
Hannah Crabtree got active on Twitter in 2016 to find more people like herself: those with Type 1 diabetes who'd hacked their insulin pumps to automatically adjust the amount of insulin delivered.
Feb 21, 2023
0
2
Stepping into the furor over eye-popping price spikes for old generic medicines, a maker of compounded drugs will begin selling $1 doses of Daraprim, whose price recently was jacked up to $750 per pill by Turing Pharmaceuticals.
Oct 22, 2015
1
94
(HealthDay)—A coalition of manufacturers has pledged to provide new prosthetic legs for victims of the Boston Marathon bombings if their health insurance won't cover the full cost of the devices.
May 1, 2013
0
0
(HealthDay)—There was a large increase in sales of electronic cigarettes (e-cigarettes) and related products in the United States in recent years as their prices fell, according to a study published online Aug. 2 in the ...
Aug 4, 2018
0
2
Average annual health care spending for individuals with employer-sponsored insurance (ESI) rose 2.9% to $6,001 per person in 2019, according to the Health Care Cost Institute's annual Health Care Cost and Utilization Report. ...
Oct 6, 2021
0
7
A growing number of new cancer drugs have come on the market in recent years, yet the cost of therapies in Europe and the United States have risen. This is driving up healthcare costs, which poses a challenge not only for ...
Apr 30, 2020
1
3
